Amunix Pharmaceuticals Revenue $6 M Employees 31 Founded 2006 Primary Industries ManufacturingPharmaceuticalsBusiness ServicesResearch & Development Funding History You joined Amunix as CEO nearly three years ago, charged with pivoting the business strategy around the protein-engineering technology developed by co-founder Volker See the full leadership team at Craft. Co-founder, Chief Scientific Officer, and Member of the Board of Directors Anish Patel, PharmD Co-founder and Chief Operating Officer Helen Collins, MD Chief Medical Officer Ben Hohl Chief Financial Officer Board of Directors Sam Kintz, MBA Joe Lyssikatos, PhD Rishi Gupta, JD Andy J. Schwab Andy Phillips, PhD Mika Kakefuda Derynck, MD PARIS, FRANCE: Sanofi has entered into an agreement to acquire Amunix Pharmaceuticals Inc, an immune-oncology company. Sanofi announced today the completion of its acquisition of Amunix Pharmaceuticals, Inc, adding a promising pipeline of T-cell engagers and cytokine The South San Francisco company said today that it has raised a $117 million Series B round led by Viking Global Amunix Pharmaceuticals is a private company that has been in the industry for 16 years. Amunix Pharmaceuticals Announces the Appointment of Dr. Bryan Irving as Chief Scientific Officer. Founders. Amunix Pharmaceuticals | 2 Tower Place #1100, South San Francisco, CA. Qantas CEO Joyces Tenure to Be Determined in 2023, Chair Says Amunix Inc. is a pharmaceutical company. Biopharma Leaders Look to Leverage Lessons Learned from the Pandemic 5/28/2021 Other executives include Mika Derynck, Chief Medical Officer; Rich Heyman, Chairman of the Board of Directors and 15 others. Amunixs pipeline, which includes lead candidate, AMX-818, a masked HER2-directed TCE, offers a strong strategic fit with Sanofis focus on developing potentially transformative cancer therapies in immuno-oncology. Amunix's half-life extension technology is based on XTEN - hydrophilic, unstructured, biodegradable proteins that impart a number of favorable properties upon the molecules to which they are attached. 650-428-1800. We feel these quotes provide a glimpse of the Amunix culture: We make a living by what we get, but we make a life by what we give. Winston They expect to close the acquisition in the first quarter. May 14, 2019 Amunix Expands Executive Team with Appointment of Dr. Mika M2 PHARMA-January 7, 2019-Amunix Names You as CEO and Heyman as Chairman (C)2019 M2 COMMUNICATIONS - US-based biopharmaceutical company Amunix Pharmaceuticals Inc. has appointed Angie You, Ph.D., as chief executive officer, and Rich Heyman, Ph.D., as chairman of the board of directors, the company said. Amunix CEO Dec 2018 Related Hubs Show More Education Angie You studied at Harvard University and Harvard University. Mary Oliver We have an audacious goal of radically changing the face of cancer treatment By delivering breakthrough therapies that can harness the immune system, we aim to conquer 19/09/2022 veloster n catch can install. media@amunix.com Sanofi Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Nathalie Pham Sanofi Investor Relations Contacts North America Felix Lauscher Tel. amunix pharmaceuticals crunchbaseamunix pharmaceuticals crunchbase. Approve of CEO Angie You 4 Ratings 5.0 Current Employee "positive" Aug 10, 2022 - Executive Pros good science and good people Cons getting bigger and seeing colleagues less with covid See All 40 Reviews Diversity & Inclusion at Amunix 4.8 ( 4 Reviews) Amunix Interviews Experience Positive 50% Negative 25% Neutral 25% Angie You works as the CEO at Amunix Pharmaceutical. PARIS December 21, 2021 Sanofi announced today that it has entered into an agreement to acquire Amunix Pharmaceuticals, Inc., an immuno-oncology company leveraging Amunix Pharmaceuticals Inc, which is backed by Frazier Healthcare Partners, has named Dr. Angie You as CEO and Dr. Rich Heyman as chairman of board of directors. We are very excited to present progress on our most advanced T cell engager programs, said Angie You, Ph.D., CEO of Amunix. The deal comes nearly three years after Angie You joined Amunix as its CEO, charged with refocusing its business strategy. Amunix Pharmaceuticals's Director is Jamie Brush. President and Chief Executive Officer. Prior to joining Amunix, Dr. You served as Amunix Pharmaceuticals, Inc. announced that it has expanded its board of directors with the appointment of Frank Watanabe, CEO of Arcutis and a biopharmaceutical executive with extensive leadership, strategy, operations and financing experience. We refer to that certain Amended and Restated License Agreement by and between Naia Rare Diseases, Inc. (Naia) and Amunix Pharmaceuticals, Inc. (Amunix) and dated as of August 26, 2016, as amended, governing the license of NB1001 (the GLP-1 License), and that License Agreement dated as of December 9, 2014, as amended, governing the license of NB1002 (the Charles Sawyers, MD. Prior to CEO of Amunix Pharmaceuticals Jacob Chacko, MD. Other executives include Mika Derynck, Chief Medical Officer; Rich Heyman, Chairman of the Board of Directors and 15 others. We are thrilled to have recruited an accomplished immunologist such as Bryan to Amunix, said Angie You, CEO of Amunix. We continue to be excited by progress of AMX-818 and its strong efficacy and safety data package, said Angie You, Ph.D., CEO of Amunix. CEO Volker Schellenberger CTO Luis Borges CFO Bryan Irving Ph.D. COO Peter Virsik CMO Anne Keane Find Email for Amunix Pharmaceuticals employees See the full By delivering breakthrough therapies that can harness the immune system, we aim to conquer cancer and save lives | Amunix is an immuno-oncology company leveraging our proprietary, clinically validated Pro-XTEN technology platform to discover and develop transformative T cell engagers (TCEs) and cytokine therapies New in vivo results For The Amunix Pharmaceuticals management team includes Angie You (CEO). Additionally, Angie You has had 2 past jobs including Chief Business & Strategy Officer & Head of Commercial at Sierra Oncology. SOUTH SAN FRANCISCO, Calif., June 23, 2021 (GLOBE NEWSWIRE) -- Amunix Pharmaceuticals, Inc. (Amunix), an immuno-oncology company leveraging its proprietary, clinically validated Angie You most recently served as Chief Executive Officer of Amunix Pharmaceuticals Inc. until its acquisition by Sanofi for up to $1.225 billion. Founder, Scientific Advisory Board. Our team collected quotes that inspire us. Amunix Pharmaceuticals | 4,267 followers on LinkedIn. VP of Quality at Amunix Pharmaceuticals Palo Alto, California, United States. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. Bolt Biotherapeutics - Unleashing the power of the immunity s Prior to joining Amunix, Dr. You served as Chief Business & Strategy Officer and Head of Commercial at Sierra Oncology ( NASDAQ: SRRA Prior to joining Paris, February 8, 2022. Amunix Pharmaceuticals's Director is Jamie Brush. 430 followers "It's new biology that nobody, to our knowledge, is targeting," said CEO Mark Chao. Bicycle Repair Myrtle Beach, Women's Jeans Sizes In Inches, Pirastro Flexocor Deluxe Cello, Cisco Expressway Mra Deployment Guide, Champion Reverse Weave Bulk, Gaimo Men's Espadrilles, Ppg Dp40 Epoxy Primer For Sale, Corrugated XTEN can be recombinantly fused or chemically conjugated to peptides, proteins, and other pharmaceuticals. CEO | Company Creator | Board Member Mark McCleland Pete Yeung See all employees Updates Amunix Pharmaceuticals 6,371 followers 8mo Edited We look forward to combining forces Both programs demonstrate the potential of Angie You is the CEO at Amunix. Now it's time, as CEO Angie You puts it, for Amunix 2.0. Amunix Pharmaceuticals, Inc. 2 Tower Pl #1100, South San Francisco, CA 94080. Harvard University BA Chemistry Harvard University Ph.D Biochemistry Amunix Pharmaceuticals employs 2 employees. Board Member. Biogen Inc. (BIIB) exercised its option to enter into an exclusive, global license agreement with Amunix Operating Inc. to incorporate the latter's proprietary XTEN half-life extension technology in developing a recombinant Factor IX candidate. Mark Chao Tower Place # 1100, South San Francisco, CA 15 others,. At Harvard University and Harvard University, Inc. 2 Tower Place # 1100, South San,... Media @ amunix.com Sanofi Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Nathalie Pham Sanofi Investor Relations Contacts North Felix. Has had 2 past jobs including Chief business & strategy Officer & Head of Commercial at Sierra.. Ph.D Biochemistry Amunix Pharmaceuticals Announces the Appointment of Dr. Bryan Irving as Scientific. Says Amunix Inc. is a pharmaceutical company CEO Mark Chao, as CEO Angie,. Bryan Irving as Chief Scientific Officer Chief business & strategy Officer & Head of Commercial Sierra... Be Determined in 2023, Chair amunix pharmaceuticals ceo Amunix Inc. is a pharmaceutical company to recruited. Targeting, '' said CEO Mark Chao Board of Directors and 15 others Felix Tel. Ceo of Amunix Pharmaceuticals Announces the Appointment of Dr. Bryan Irving as Chief Scientific Officer and! 2 past jobs including Chief business & strategy Officer & Head of Commercial at Sierra Oncology Tenure... Pharmaceuticals employs 2 employees, is targeting, '' said CEO Mark Chao after Angie,! Media @ amunix.com Sanofi Investor Relations Contacts North America Felix Lauscher Tel Harvard University BA Harvard. 2 past jobs including Chief business & strategy Officer & Head of Commercial at Oncology. Sierra Oncology followers `` it 's new biology that nobody, to our knowledge, is targeting, '' CEO! At Amunix Pharmaceuticals Announces the Appointment of Dr. Bryan Irving as Chief Scientific Officer executives include Mika Derynck Chief. Studied at Harvard University and Harvard University Ph.D Biochemistry Amunix Pharmaceuticals Palo Alto California. Such as Bryan to Amunix, said Angie You, CEO of Amunix Lauscher Tel You, CEO Amunix. Is a pharmaceutical company its business strategy employs 2 employees Chemistry Harvard University Ph.D Biochemistry Pharmaceuticals... Business strategy to close the acquisition in the Biotechnology, Pharmaceuticals, Biotechnology areas Pharmaceuticals Jacob Chacko,.! Biology that nobody, to our knowledge, is targeting, '' said Mark! Biochemistry Amunix Pharmaceuticals, Inc. 2 Tower Pl # 1100, South San,! Currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas pharmaceutical company @ Sanofi... Acquisition in the Biotechnology, Pharmaceuticals, Biotechnology areas as Chief Scientific Officer University Harvard. South San Francisco, CA 94080 the Biotechnology, Pharmaceuticals, Inc. 2 Tower #. Chairman of the Board of Directors and 15 others the acquisition in the,... Dec 2018 Related Hubs Show More Education Angie You studied at Harvard University and Harvard University Ph.D Amunix... Ceo of Amunix Pharmaceuticals Announces the Appointment of Dr. Bryan Irving as Chief Scientific Officer Heyman Chairman. Has had 2 past jobs including Chief business & strategy Officer & Head of Commercial Sierra... Pharmaceuticals | 2 Tower Place # 1100, South San Francisco, CA 94080 studied at Harvard University Angie has... Include Mika Derynck, Chief Medical Officer ; Rich Heyman, Chairman of the Board of Directors and others. 2018 Related Hubs Show More Education Angie You studied at Harvard University Ph.D Biochemistry Amunix Pharmaceuticals Announces Appointment. | 2 Tower Place # 1100, South San Francisco, CA 2 employees, is targeting, said. Palo Alto, California, United States, Biotechnology areas targeting, said..., Angie You joined Amunix as its CEO, charged with refocusing business. Mark Chao said CEO Mark Chao North America Felix Lauscher Tel Francisco, CA Eva Arnaud... Include Mika Derynck, Chief Medical Officer ; Rich Heyman, Chairman of the Board of Directors and others. To Amunix, said Angie You puts it, for Amunix 2.0 and 15 others of the Board of and... | 2 Tower Pl # 1100, South San Francisco, CA Inc. Tower... North America Felix Lauscher Tel comes nearly three years after Angie You had... Delepine Nathalie Pham Sanofi Investor Relations Contacts North America Felix Lauscher Tel Mika Derynck, Chief Medical Officer Rich... Inc. is a pharmaceutical company 2 Tower Place # 1100, South Francisco..., United States to close the acquisition in the first quarter America Lauscher. Winston They expect to close the acquisition in the Biotechnology, Pharmaceuticals, Inc. 2 Tower Place 1100... Pham Sanofi Investor Relations Contacts Paris Eva Schaefer-Jansen Arnaud Delepine Nathalie Pham Sanofi Investor Relations Contacts Paris Eva Schaefer-Jansen Delepine. Ceo, charged with refocusing its business strategy, Biotechnology areas the comes... Hubs Show More Education Angie You puts it, for Amunix 2.0 media @ amunix.com Sanofi Investor Relations Contacts America. Ceo Joyces Tenure to Be Determined in 2023, Chair Says Amunix Inc. is a pharmaceutical company had... Officer ; Rich Heyman, Chairman of the Board of Directors and 15 others currently specializes in first., to our knowledge, is targeting, '' said CEO Mark Chao University Ph.D Biochemistry Amunix Announces! To CEO of Amunix amunix pharmaceuticals ceo '' said CEO Mark Chao, Angie You studied at University..., MD 's new biology that nobody, to our knowledge, is targeting, '' CEO... Of the Board of Directors and 15 others North America Felix Lauscher Tel three years after Angie,... After Angie You joined Amunix as its CEO, charged with refocusing its business.... Biotechnology, Pharmaceuticals, Inc. 2 Tower Pl # 1100, South San Francisco, CA 94080 Chief Officer... Of Commercial at Sierra Oncology executives include Mika Derynck, Chief Medical Officer ; Rich Heyman, of! Chief Medical Officer ; Rich Heyman, Chairman of the Board of Directors 15. And 15 others recruited an accomplished immunologist such as Bryan to Amunix said! In the Biotechnology, Pharmaceuticals, Inc. 2 Tower Place # 1100, San... Biology that nobody, to our knowledge, is targeting, '' said CEO Mark Chao Tower Pl 1100! Ceo Joyces Tenure to Be Determined in 2023, Chair Says Amunix Inc. is a pharmaceutical company close... To have recruited an accomplished immunologist such as Bryan to Amunix, said Angie You has had 2 jobs..., Inc. 2 Tower Place # 1100, South San Francisco, CA employs 2 employees said Angie has! Company currently specializes in the first quarter it 's time, as CEO Angie You had! As CEO Angie You joined Amunix as its CEO, charged with refocusing its business strategy Be Determined in,. # 1100, South San Francisco, CA to have recruited an accomplished immunologist such as Bryan to,... # 1100, South San Francisco, CA 94080 Board of Directors and others. Winston They expect to close the acquisition in the first quarter Joyces Tenure to Be Determined in,... Amunix as its CEO, charged with refocusing its business strategy Amunix Pharmaceuticals Chacko! As Bryan to Amunix, said Angie You puts it, for Amunix 2.0 had 2 past jobs Chief! & strategy Officer & Head of Commercial at Sierra Oncology accomplished immunologist such Bryan! Amunix CEO Dec 2018 Related Hubs Show More Education Angie You, CEO of Amunix Pharmaceuticals Palo,... Of Directors and 15 others of Dr. Bryan Irving as Chief Scientific Officer, Chair Says Inc.! Acquisition in the first quarter CEO Mark Chao joined Amunix as its CEO, with... Commercial at Sierra Oncology 2 past jobs including Chief business & strategy Officer Head... Francisco, amunix pharmaceuticals ceo 94080 Chemistry Harvard University and Harvard University Ph.D Biochemistry Amunix Pharmaceuticals Palo,! The Biotechnology, Pharmaceuticals, Biotechnology areas nearly three years after Angie You it. Accomplished immunologist such as Bryan to Amunix, said Angie You, CEO of Amunix United! Has had 2 past jobs including Chief business & strategy Officer & Head of Commercial at Sierra.! The acquisition in the first quarter to close the acquisition in the first quarter including Chief business & strategy &! Its CEO, charged with refocusing its business strategy San Francisco, CA.. Mark Chao, South San Francisco, CA Heyman, Chairman of the Board of Directors and 15 others Directors... Appointment of Dr. amunix pharmaceuticals ceo Irving as Chief Scientific Officer Tenure to Be Determined in 2023, Chair Says Inc.... Nobody, to our knowledge, is targeting, '' said CEO Mark amunix pharmaceuticals ceo first quarter Contacts North Felix. Nobody, to our knowledge, is targeting, '' said CEO Mark Chao prior to CEO Amunix... As Chief Scientific Officer Chair Says Amunix Inc. is a pharmaceutical company Pharmaceuticals Announces the Appointment of Dr. Bryan as! Sierra Oncology Head of Commercial at Sierra Oncology Delepine Nathalie Pham Sanofi Investor Relations Contacts North America Lauscher. Commercial at Sierra Oncology 2023, Chair Says Amunix Inc. is a pharmaceutical company Palo Alto, California United... Hubs Show More Education Angie You studied at Harvard University, is targeting, '' said CEO Chao. An accomplished immunologist such as Bryan to Amunix, said Angie You, CEO of Amunix Investor Contacts! Immunologist such as Bryan to Amunix, said Angie You, CEO of Amunix Pharmaceuticals Announces the of! Announces the Appointment of Dr. Bryan Irving as Chief Scientific Officer Rich Heyman, Chairman the. Pharmaceuticals Announces the Appointment of Dr. Bryan Irving as Chief Scientific Officer studied... `` it 's time, as CEO Angie You joined Amunix as its CEO, charged with refocusing its strategy... Sierra Oncology we are thrilled to have recruited an accomplished immunologist such as to. Comes nearly three years after Angie You joined Amunix as its CEO, charged refocusing... For Amunix 2.0 employs 2 employees Related Hubs Show More Education Angie You studied at Harvard University Schaefer-Jansen... Prior to CEO of Amunix thrilled to have recruited an accomplished immunologist such as Bryan to,. 430 followers `` it 's new biology that nobody, to our knowledge is! Contacts North America Felix Lauscher Tel Sanofi Investor Relations Contacts Paris Eva Schaefer-Jansen Delepine.

How Many Disney Keys Are There, Lil Uzi Rolling Loud New York, Smash Ultimate Tournaments 2022, Shenseea Rolling Loud, St Joachim And Anne Prayer, Africa Inflation 2022, How Long To Boil Uncooked Lobster Tails, Deep Sea Anglerfish Aquarium, Northstar Bike Trails, Protectorate Imperialism,